Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix begins treating patients in phase II study of FMdC

Feb. 26, 1999

Magainin reports interim results of squalamine trial

Feb. 26, 1999

FDA grants priority review status to U.S. Bioscience's sNDA for Ethyol

Feb. 25, 1999

Ilex Oncology initiates phase III trial of DFMO

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

NCI to conduct phase III trial of pure shark cartilage

Feb. 24, 1999

Orphan Medical launches improved form of busulfan in U.S.

Feb. 24, 1999

U.S. patent extends coverage for Immune Response's TCR vaccine technology

Feb. 24, 1999

Immunomedics and NCI to study new class of anticancer agents

Feb. 24, 1999

NeoPharm and Pharmacia & Upjohn reach licensing agreement for liposomal cancer formulations

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...